Multidisciplinary

Top Medical News
Stephen Padilla, 17 minutes ago
The belief that individuals who commit nonsuicidal self-injury (NSSI) are doing it only to seek attention only perpetuates the stigma and prevents these people from seeking appropriate treatment and psychological care, according to a Singapore study.
an hour ago
A recent study that defined the disease course of penile calciphylaxis has reported high mortality among patients with such condition and suggests imaging to aid in its diagnosis. End-stage renal disease, hyperparathyroidism, and normal body mass index are significantly associated with this rare disorder.
4 hours ago
Women who spend greater time participating in moderate physical activity are at lower risk of developing stress, urge, and mixed incontinence, as suggested in a recent study.
6 hours ago
Some patients with SARS-CoV-2 may subsequently develop Guillain-Barré syndrome, although this occurrence is infrequent and a causative link cannot be determined, as reported in a study.
Elaine Soliven, 12 hours ago
Intramuscular administration of single-dose AZD7442, a combination of two long-acting monoclonal antibodies (tixagevimab and cilgavimab), significantly reduced the risk of developing symptomatic COVID-19 in adults, according to the PROVENT* study presented at IDWeek 2021.
Roshini Claire Anthony, 18 hours ago

In patients with chronic plaque psoriasis, once-daily treatment with roflumilast improved severity and burden of itch compared with vehicle cream, according to results of the phase III DERMIS-1 and DERMIS-2 trials presented at EADV 2021.

18 hours ago
Acute surgical repair of large para-oesophageal hernias (POH) can be safely performed, yielding low morbidity and mortality rates, and leads to improved quality of life (QoL) among patients, a recent study has found.
Special Reports
01 Oct 2021
During the recent EMPIRE SUMMIT, Professor Dr Chee Kok Han discussed the importance of an early, patient-centred,multi factorial approach in managing type 2 diabetes mellitus(T2DM). Specifically, Professor Chee highlighted the role ofempagliflozin (Jardiance®, Boehringer Ingelheim) in conferring cardiorenal protection to patients with T2DM.
01 Oct 2021
Psoriasis is characterised by well-circumscribed, erythematous, scaly plaques and can be categorised as eitherlocalised or generalised, depending on the severity of the disease and its impact on patients’ quality of life. The mainstay of treatment for localised disease includes topical therapy with corticosteroids, calcipotriene and coal tar products, while generalised psoriasis may require more advanced forms of treatment like phototherapy and systemic therapy. In this case study, Dr Preamala Gunabalasingam shares her clinical experience treating.2plaque psoriasis with a combined formulation of betamethasone dipropionate and calcipotriol monohydrate in a single spray foam (Enstilar® Foam, LEO Pharma). 
29 Sep 2021
Edoxaban 30 mg and 60 mg FC tab
29 Sep 2021
Isavuconazole 100 mg hard cap and 200 mg infusion conc
29 Sep 2021
Cabozantinib 60 mg, 40 mg and 20 mg tab
29 Sep 2021
Sevelamer Carbonate 800 mg FC tab
15 Sep 2021
The FreeStyle Libre™ flash glucose monitoring system includes a sensor which automatically measures and continuously stores up to 8 hours of glucose readings, allowing patients to monitor their glucose levels without the need for painful finger pricks. Physicians play an important role in reviewing and analysing glucose data that is available through LibreView to support patient management.
Conference Reports
Elaine Soliven, 20 Oct 2021
Intramuscular administration of single-dose AZD7442, a combination of two long-acting monoclonal antibodies (tixagevimab and cilgavimab), significantly reduced the risk of developing symptomatic COVID-19 in adults, according to the PROVENT* study presented at IDWeek 2021.
Roshini Claire Anthony, 19 Oct 2021

In patients with chronic plaque psoriasis, once-daily treatment with roflumilast improved severity and burden of itch compared with vehicle cream, according to results of the phase III DERMIS-1 and DERMIS-2 trials presented at EADV 2021.

Roshini Claire Anthony, 18 Oct 2021

A 3-day course of remdesivir may help stave off COVID-19–related hospitalization and death, according to results of the phase III PINETREE study.

Elvira Manzano, 18 Oct 2021
Treatment with the nonsteroidal topical cream tapinarof 1% for up to 52 weeks helps control plaque psoriasis in the phase III PSOARING 3 trial.
Pearl Toh, 16 Oct 2021
The oral selective JAK*1 inhibitor abrocitinib is superior to dupilumab for relieving itch and achieving skin clearance in people with moderate-to-severe atopic dermatitis (AD), according to results from a head-to-head comparison in the JADE DARE trial presented at EADV 2021.
Roshini Claire Anthony, 15 Oct 2021

Mortality following bariatric surgery is rare but more common in men than women, according to a retrospective study from Austria presented at EASD 2021.

Roshini Claire Anthony, 14 Oct 2021

Baricitinib, an oral, selective Janus kinase (JAK)1/JAK2 inhibitor, may help improve hair growth in patients with severe alopecia areata, according to results from the phase III BRAVE-AA1 and BRAVE-AA2 trials.